SANTA CRUZ, Calif.–(BUSINESS WIRE)–Murj, Inc., a digital healthcare company dedicated to helping clinicians streamline and improve care for patients with implantable cardiac devices, today announced that the company has closed an $8.5 million Series B financing led by Longitude Capital, with participation from True Ventures and other existing investors.
Murj intends to use the proceeds to continue commercial expansion of its cloud-based cardiac device management platform, which eliminates the burdens of inefficient workflow processes and outdated device management systems. Concurrent with the financing, Marc Galletti, Managing Director of Longitude Capital, will join the company’s board of directors.
“We are thrilled to have the support of Longitude Capital and our existing investors,” said Todd Butka, Murj’s founder and CEO. “Cardiac clinics are seeking solutions that improve workflow productivity and deliver greater clinical insight, and the customer success of the past year is evidence that our platform delivers the solutions clinicians need. We look forward to working with Longitude Capital as we introduce Murj to a growing customer base.”
The need for streamlined device management is acute. New innovative implantable cardiac devices and an aging U.S. population are combining to increase the volume of devices that need to be managed. Many of these new cardiac devices provide a near-constant stream of data that must be triaged by care providers. Existing workflow solutions can’t accommodate this rapid increase in devices and data, placing an overwhelming burden on care providers. Murj provides a more efficient path for clinics to monitor, process, and care for their device patients.
As a cloud-based solution, Murj can be activated in as little as 24 hours and requires no software to install or maintain. The solution supports implantable cardiac devices from all major device manufacturers in all care modalities, including in-office interrogations and remote transmissions. Murj combines a patent-pending user interface, intelligent care workflow, and actionable insight to dramatically improve productivity and clinical insight.
“We are impressed with the Murj team’s dedication to their mission and believe the company’s technology is an unmatched, best-in-class solution,” said Mr. Galletti. “Murj is delivering much-needed innovation in the cardiac clinic to improve patient care and clinic workflows, and we look forward to helping them expand their leadership position.”
The company will exhibit at the Heart Rhythm Society Scientific Sessions 2018, in Boston, Mass. May 9-12, in booth number 773.
About Murj
Murj is a healthcare technology company reimagining the quality and efficiency of implantable cardiac device care. Murj delivers a new vision for patient insight and clinical efficiency, meeting the challenge of rapid device growth and data expansion, and freeing clinicians to get back to the heart of the matter— their patients. For more information visit www.murj.com.
